{
    "Trade/Device Name(s)": [
        "VITROS\u00ae Immunodiagnostic Products NT-proBNP II Reagent Pack",
        "VITROS NT-proBNP II"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K201312",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072437"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBC"
    ],
    "Summary Letter Date": "November 6, 2020",
    "Summary Letter Received Date": "November 9, 2020",
    "Submission Date": "September 23, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.1117"
    ],
    "Regulation Name(s)": [
        "B-Type Natriuretic Peptide Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cardiology"
    ],
    "Analyte(s)": [
        "N-terminal pro Brain Natriuretic Peptide (NT-proBNP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (K2 EDTA)",
        "Plasma (Lithium Heparin)"
    ],
    "Specimen Container(s)": [
        "Serum plus clot activator plastic tube",
        "K2-EDTA plasma plastic tube",
        "Lithium heparin plasma plastic tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VITROS 3600 Immunodiagnostic System",
        "VITROS Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Immunometric bridging assay",
        "Chemiluminescent detection"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent Pack",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Ortho Clinical Diagnostics VITROS NT-proBNP II Reagent Pack for quantitative NT-proBNP measurement in serum and plasma to aid in heart failure diagnosis and assessment using the VITROS 3600 Immunodiagnostic System",
    "Indications for Use Summary": "For in vitro diagnostic use for quantitative measurement of NT-proBNP in human serum and plasma (K2 EDTA or Lithium Heparin) using the VITROS 3600 Immunodiagnostic System to aid in the diagnosis and severity assessment of heart failure in diagnosed patients",
    "fda_folder": "Clinical Chemistry"
}